NOVO.B

Market closed
Access this stock data via API
Subscribe
Novo Nordisk A/S
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 290.4B 232.3B 177.0B 140.8B
Cost of revenue 44.5B 35.8B 28.4B 23.7B
Gross profit 245.9B 196.5B 148.5B 117.1B
Operating expense
Research & development 48.1B 32.4B 24.0B 17.8B
Selling general and admin 67.4B 61.6B 50.7B 41.1B
Other operating expenses 2.1B -119M -1.0B -332M
Operating income 128.3B 102.6B 74.8B 58.6B
Non operating interest income
Income 1.8B 1.1B 239M 231M
Expense 1.6B 542M 378M 289M
Other income expense -1.1B 1.8B -5.4B 616M
Pretax income 127.2B 104.7B 69.1B 59.1B
Tax provision 26.2B 21.0B 13.5B 11.3B
Net income 101.0B 83.7B 55.5B 47.8B
Basic EPS 22.7 18.7 12.3 10.4
Diluted EPS 22.6 18.6 12.2 10.4
Basic average shares 4.5B 4.5B 4.5B 4.6B
Diluted average shares 4.5B 4.5B 4.5B 4.6B
EBITDA 138.4B 112.9B 82.0B 64.8B
Net income from continuing op. 101.0B 83.7B 55.5B 47.8B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 1 hour 35 minutes

07:24
00:00
09:00
17:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:00
All times are displayed in the Europe/Copenhagen timezone (CET, UTC+01:00).